Polymorphous low-grade adenocarcinoma (PLGA) ofthe parotid gland is rare. We describe a new case in which the patient underwent parotidectomy only to experi ence an extensive recurrence 2 years later: The recurrence was treated with radical surgical excision and radiation therapy, and the patient remained disease -free at 5 years of follow-up . We also review the literature on primary parotid PLGA.
Introduction
Polymorphous low-grade adenocarcinoma (PLOA) is an uncommon salivary gland tumor that usually arises from a minor salivary gland. Origin in the parotid gland is rare; to the best of our knowledge, only 28 cases have been previously reported in the literature. Although PLOA is considered to be a low-grade tumor, it does occasionally exhibit two characteristics of malignancy-extensive local infiltration and perineural spread-and therefore it has a propensity for local recurrence. In this article, we describe a new case of prim ary parotid PLOA, and we review the literature.
Case report
A 45-year-old man presented with an 18-month history of a gradually enlarging left cheek mass . Two years earlier, he had undergone parotidectomy for the treatment of a benign lesion at another institution. The new mass had begun as a painless swelling that progressed to intraoral fullne ss in the left cheek and soft palate. The mass was not associated with any dysphagia , odynophagia, dysphonia, pain , or bleeding. An oral surgeon performed a trans oral biop sy, the results of which were report ed as consi stent with a pleomorphic adenoma. The .physical examination was significant for the presence of an extensive parotid lesion (figure I, A). The mass measured 20 x II em , and it was firm, nontender, and noncompressible . It occupied the area of the left parotid gland and extended medially to involve the entire left buccal muco sa. The intraoral component extended into the maxilla and soft palate, displacing the tonsil medially and filling the left side of the oral cavity and oropharynx (figure I, B). Weakness of the left marginal mandibular branch of the facial nerve was present. A well-healed Blair incision from the previous parotidectomy was noted.
Computed tomography (CT) ofthe facial bone s revealed that a large , heterogenous parotid mas s had filled the left masticator space and eroded the body and angle of the mandible and the left maxilla, with effacement of the oropharynx (figure 2). No lymphadenopathy was seen, and a metastatic workup was negative.
The patient was taken to surgery, where he underwent a left total parotidectomy with facial nerve sacrifice and mandibular resection in continuity with wide local excision of the soft palate and buccal mucosa, a partial maxillectomy, and an ipsilateral modified radical neck dissection. Histologic examination revealed that the mass was a PLOA; it was made up of clusters of cells with predominantly round to oval nuclei, small nucleoli, and scant cytoplasm arranged in island s surrounded by a mucohyaline stroma ( figure 3 ). In other areas of the mass, central tumor necro sis and incre ased mitotic activity were noted. The tumor had focally infiltrated the mandible, but bone and soft-tissue resection margins were negative for tumor involvement. Many areas of lymphovascular and perineural invasion were seen. No metastasi s to cer vical lymph nodes was identified.
The patient underwent postoperative rad iation therapy to 5,000 cOy. At 5 years of follo w-up, he exhibited no evidence of recurrence.
Discussion
PLOAs account for 10% of all tumors of the minor sali vary glands and 25 % of all malignancies of the minor salivary glands.' The origin of this tumor in a major salivary gland is rare. The first cases of a PLGA arising from the parotid were published almost simultaneously in 1991 by George et aP and Mili auskas.' To the best of our knowledge, onl y 27 other cases ofprimary parotid PLGA have been reported in the literatur e since then , including ours. There are no reports of PLGA arising from the submandibular gland."
Before its characterization as a separate dia gnostic entity in 1983 , PLGA was clas sified as a variant of pleomorphic adenoma, a vari ant of monomorphic ade noma , an adenoid cy stic carcinoma, a malignant mixed tumor, and an adenocarcinoma not otherwise spe cified .v" Primary parotid PLGA pre sent s as a slowly growing, asymptomatic tumor that most often involves the superficial lobe .v' :" Demographic characteristics of patients with major and minor salivary gland PLGAs are similar, with the possible ex ception of some sex differences; Kemp et al reported that the female-to-m ale ratio was 7: I for major salivary gland tumors and 2: I for minor gland tumors." Most patients pre sent in the fifth dec ade of life .6
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The recurrence rate of parotid PLGA has been reported to be 33 .3% ; recurrences have been dia gnosed as long as 8 to 10 yea rs after the initial present ation and treat- histolo gic structure, (2) contain papill ary structures more often, and (3) exhibit less perineural invasion. t? PLGA cytology is characterized by the presence of cuboidal cells with abunda nt cytopl asm, round to oval nuclei, and inconspicuous nucleoli. ' .5.10 Mitoti c figure s are rarely seen.' > Immunohistochemical staining can assist in makin g a diagnosis of PLGA, as 90% of cells stain positively with S-IOO protein and epith elial membrane antigen (EMA) .IO The result s ofstaining with high-m olecular-weight keratin are somewhat more variable, as 75 to 95% of the cell s stain positively. Muscle-specific actin and carcinoembryonic antigen are poor mark ers of PLGA because of their high variability in staining. 10 PLGAmay stain with glial fibrillary acidic protein (GFAP), but this is usually less consistent than is GFAP staining of pleomorphic adenomas. Most PLGAs stain poorl y with proliferation markers p53 and Ki-67 , which supports the clinic al observation that PLGAs are slowly growing tumors.' Differential diagnosis. Because PLGA s share many of the histolo gic characteristics of pleomorphic adenomas, mon om orphic adenomas, ade noid cystic carcinomas, and low -grade papillary adenocarc inomas, these other tumors should be considered in the differenti al diagno sis of PLGA.s Pleom orphic adenoma s. PLGA s and pleomorphic adenomas are best distinguished by the presence of PLG A charac teristics, such as poor circum script ion, peripheral infiltration, and the tendency for perineural inva sion.t-:'?
Monom orphic adenoma s. PLGA s are best differentiated from monomorphic adenomas on the basis of a PLGA's infiltrative borders.'
Adenoid cystic carcinomas. PLGA s and adenoid cystic carcinomas may both displa y cribriform patterns, local infiltration, and perineu ral inva sion , but they can be distinguished from one another by cytology; adenoid cystic Volume 85, Number 10 carcinomas exhibit basaloid cells with sca nt cytoplasm.1. 6.7 In addition, PLGAs show spindling, and adenoid cystic carcinomas do not. S • 1O Finally, while PLGAs stain wide ly with Sol 00 protein and EMA, adenoid cys tic carcinom as stain much less diffu sely.'?
Low-grade papillary adenocarcinomas. A distinction should be made between PLGA s and low-grade papill ary aden ocarcin oma s becau se the latter displ ay a more aggress ive beha vior; their rates of both local recurrence and regional lymph node metastasis are higher.l'v'Mcst authors agree that if the histologic featur es are predominately papill ary, the tumor should be identified as a low-grade papillary adenocarcinoma.I-v':!"
Treatment. The treatm ent of choice for PLGA is wide local exci sion with clear margin s. The facial nerve should be preserved unless tumor infiltration precludes complete removal without ner ve sacrifice. Postoperative radiation therap y is reserved for cases of positi ve or close surgical margins, but it has not been shown to alter outcome in patient s without lymph node metastasis." The presenc e of cervical metastasis is considered an indicati on for adju vant radiation therapy. For the treatm ent of recurrences, radical excision is warranted.' Follow-up. No patient has died as a dire ct result of a prim ary PLGA of the parotid, alth ough a few deaths have been attributed to local extension of a minor salivary gland PLGA into vital structures.' Local recurrence can occur many years after the initial presentation , so lifelong fol-lOW-Up is warranted.P"
